The surge in interest for pharmacogenomics is poised to redefine conventional approaches to patient care, with projections indicating a market volume of USD 10.54 billion by 2035. This significant growth trajectory, highlighted by a CAGR of 7.47%, emphasizes the escalating demand for customized medication strategies. By leveraging genetic insights, healthcare providers can enhance treatment...